Global Sarcopenia Treatments Competitive Landscape Professional Research Report 2024

Report Format: PDF   |   Report ID: 5685928   |   Published Date: August 2024   |   Pages:  170+  

Research Summary
Sarcopenia treatments encompass a variety of strategies aimed at mitigating or reversing the loss of skeletal muscle mass, strength, and function associated with aging. These treatments typically involve a combination of exercise, nutrition, and pharmacological interventions tailored to the individual's needs and health status. Resistance training, such as weightlifting or bodyweight exercises, is a cornerstone of sarcopenia treatment, as it helps stimulate muscle growth and strength. Adequate protein intake, along with balanced nutrition, is crucial to support muscle repair and maintenance. In some cases, healthcare providers may prescribe medications such as anabolic steroids, growth hormone, or certain medications targeting muscle metabolism to supplement exercise and nutrition interventions. Additionally, addressing underlying medical conditions, optimizing hormone levels, and promoting overall health and well-being are integral components of sarcopenia management. Early detection and intervention are key to effectively managing sarcopenia and preserving muscle mass and function in older adults.
According to DIResearch's in-depth investigation and research, the global Sarcopenia Treatments market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Sarcopenia Treatments include Abbott Laboratories, Nestl?(C), Pfizer, Amway, By-health, Usana, A&Z Pharmaceutical, GlaxoSmithKline, H&H, Bayer, Blackmores, Zhendong Group etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Sarcopenia Treatments. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Sarcopenia Treatments market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Sarcopenia Treatments market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Sarcopenia Treatments industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Sarcopenia Treatments Include:
Abbott Laboratories
Nestl?(C)
Pfizer
Amway
By-health
Usana
A&Z Pharmaceutical
GlaxoSmithKline
H&H
Bayer
Blackmores
Zhendong Group
Sarcopenia Treatments Product Segment Include:
Protein Supplement
Calcium Supplement
Other
Sarcopenia Treatments Product Application Include:
Online Pharmacies
Retail Pharmacies
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Sarcopenia Treatments Industry PESTEL Analysis
Chapter 3: Global Sarcopenia Treatments Industry Porter's Five Forces Analysis
Chapter 4: Global Sarcopenia Treatments Major Regional Market Size and Forecast Analysis
Chapter 5: Global Sarcopenia Treatments Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Sarcopenia Treatments Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Sarcopenia Treatments Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Sarcopenia Treatments Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Sarcopenia Treatments Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Sarcopenia Treatments Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Sarcopenia Treatments Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Sarcopenia Treatments Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents

1 Sarcopenia Treatments Market Overview

1.1 Product Definition and Statistical Scope

1.2 Sarcopenia Treatments Product by Type

1.2.1 Global Sarcopenia Treatments Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Protein Supplement

1.2.3 Calcium Supplement

1.2.4 Other

1.3 Sarcopenia Treatments Product by Application

1.3.1 Global Sarcopenia Treatments Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Online Pharmacies

1.3.3 Retail Pharmacies

1.4 Global Sarcopenia Treatments Market Revenue Analysis (2019-2030)

1.5 Sarcopenia Treatments Market Development Status and Trends

1.5.1 Sarcopenia Treatments Industry Development Status Analysis

1.5.2 Sarcopenia Treatments Industry Development Trends Analysis

2 Sarcopenia Treatments Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Sarcopenia Treatments Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Sarcopenia Treatments Market Analysis by Regions

4.1 Sarcopenia Treatments Overall Market: 2023 VS 2024 VS 2030

4.2 Global Sarcopenia Treatments Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Sarcopenia Treatments Revenue and Market Share by Region (2019-2024)

4.2.2 Global Sarcopenia Treatments Revenue Forecast by Region (2025-2030)

5 Global Sarcopenia Treatments Market Size by Type and Application

5.1 Global Sarcopenia Treatments Market Size by Type

5.2 Global Sarcopenia Treatments Market Size by Application

6 North America

6.1 North America Sarcopenia Treatments Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Sarcopenia Treatments Market Size by Type

6.4 North America Sarcopenia Treatments Market Size by Application

6.5 North America Sarcopenia Treatments Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Sarcopenia Treatments Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Sarcopenia Treatments Market Size by Type

7.4 Europe Sarcopenia Treatments Market Size by Application

7.5 Europe Sarcopenia Treatments Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Sarcopenia Treatments Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Sarcopenia Treatments Market Size by Type

8.4 China Sarcopenia Treatments Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Sarcopenia Treatments Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Sarcopenia Treatments Market Size by Type

9.4 APAC (excl. China) Sarcopenia Treatments Market Size by Application

9.5 APAC (excl. China) Sarcopenia Treatments Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Sarcopenia Treatments Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Sarcopenia Treatments Market Size by Type

10.4 Latin America Sarcopenia Treatments Market Size by Application

10.5 Latin America Sarcopenia Treatments Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Sarcopenia Treatments Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Sarcopenia Treatments Market Size by Type

11.4 Middle East & Africa Sarcopenia Treatments Market Size by Application

11.5 Middle East & Africa Sarcopenia Treatments Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Sarcopenia Treatments Market Revenue by Key Manufacturers (2020-2024)

12.2 Sarcopenia Treatments Competitive Landscape Analysis and Market Dynamic

12.2.1 Sarcopenia Treatments Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Abbott Laboratories

13.1.1 Abbott Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Abbott Laboratories Sarcopenia Treatments Product Portfolio

13.1.3 Abbott Laboratories Sarcopenia Treatments Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Nestl?(C)

13.2.1 Nestl?(C) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Nestl?(C) Sarcopenia Treatments Product Portfolio

13.2.3 Nestl?(C) Sarcopenia Treatments Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Pfizer

13.3.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Pfizer Sarcopenia Treatments Product Portfolio

13.3.3 Pfizer Sarcopenia Treatments Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Amway

13.4.1 Amway Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Amway Sarcopenia Treatments Product Portfolio

13.4.3 Amway Sarcopenia Treatments Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 By-health

13.5.1 By-health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 By-health Sarcopenia Treatments Product Portfolio

13.5.3 By-health Sarcopenia Treatments Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Usana

13.6.1 Usana Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Usana Sarcopenia Treatments Product Portfolio

13.6.3 Usana Sarcopenia Treatments Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 A&Z Pharmaceutical

13.7.1 A&Z Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 A&Z Pharmaceutical Sarcopenia Treatments Product Portfolio

13.7.3 A&Z Pharmaceutical Sarcopenia Treatments Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 GlaxoSmithKline

13.8.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 GlaxoSmithKline Sarcopenia Treatments Product Portfolio

13.8.3 GlaxoSmithKline Sarcopenia Treatments Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 H&H

13.9.1 H&H Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 H&H Sarcopenia Treatments Product Portfolio

13.9.3 H&H Sarcopenia Treatments Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Bayer

13.10.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Bayer Sarcopenia Treatments Product Portfolio

13.10.3 Bayer Sarcopenia Treatments Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Blackmores

13.11.1 Blackmores Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Blackmores Sarcopenia Treatments Product Portfolio

13.11.3 Blackmores Sarcopenia Treatments Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Zhendong Group

13.12.1 Zhendong Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Zhendong Group Sarcopenia Treatments Product Portfolio

13.12.3 Zhendong Group Sarcopenia Treatments Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Sarcopenia Treatments Industry Chain Analysis

14.2 Sarcopenia Treatments Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Sarcopenia Treatments Typical Downstream Customers

14.4 Sarcopenia Treatments Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Publisher: DIResearch
Choose License
Related Reports

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support